[1] World Health Organization.Global tuberculosis report 2024. Geneva: World Health Organization, 2024. [2] 李果,庞先琼,徐华,等. 潜伏性结核感染诊治进展[J]. 中国防痨杂志,2021,43(1):91-95. [3] 王泽明,申阿东. 《儿童结核分枝杆菌潜伏感染检测和预防性治疗》标准解读[J]. 中国防痨杂志,2023,45(1):13-17. [4] 张静,付若楠,王森路,等. 高负担地区肺结核密切接触者中结核分枝杆菌潜伏感染者预防性治疗接受意愿及影响因素研究[J]. 中国防痨杂志,2024,46(2):165-172. [5] 宋媛媛,李涛,夏辉,等. 1997—2023年全国肺结核报告发病流行病学特征[J]. 中国防痨杂志,2024,46(10):1198-1208. [6] Hsu MS, Chung TC, Wang PH, et al.Revisiting the association between vitamin D deficiency and active tuberculosis: A prospective case-control study in Taiwan[J]. J Microbiol Immunol Infect, 2024, 57(3): 490-497. [7] Zhou Y, Wu Q, Wang F, et al.Association of variant vitamin statuses and tuberculosis development: A systematic review and meta-analysis[J]. Ann Med, 2024, 56(1): 2396566. [8] Singh M, Vaughn C, Sasaninia K, et al.Understanding the relationship between Glutathione, TGF-β, and vitamin D in combating Mycobacterium tuberculosis infections[J]. J Clin Med, 2020, 9(9): 2757. [9] Ganmaa D, Khudyakov P, Buyanjargal U, et al.Prevalence and determinants of QuantiFERON-Diagnosed tuberculosis infection in 9810 Mongolian schoolchildren[J]. Clin Infect Dis, 2019, 69(5): 813-819. [10] Arnedo-Pena A, Juan-Cerdán JV, Romeu-Garcia M, et al.Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain[J]. Int J Tuberc Lung Dis, 2020, 24(3): 278-286. [11] Black LJ, Dunlop E, Lucas RM, et al.Prevalence and predictors of vitamin D deficiency in a nationally representative sample of Australian Aboriginal and Torres Strait Islander adults[J]. Br J Nutr, 2021, 126(1): 101-109. [12] Balcells ME, García P, Tiznado C, et al.Association of vitamin D deficiency, season of the year, and latent tuberculosis infection among household contacts[J]. PLoS One, 2017, 12(4): e0175400. [13] Venturini E, Facchini L, Martinez-Alier N, et al.Vitamin D and tuberculosis: A multicenter study in children[J]. BMC Infect Dis, 2014, 14: 652. [14] Arnedo-Pena A, Juan-Cerdán JV, Romeu-Garcia A, et al.Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: A cross-sectional and case-control study[J]. BMC Infect Dis, 2011, 11: 349. [15] 何翼君,曹雪芳,高磊. 《结核菌素皮肤试验-γ干扰素释放试验两步法的操作技术规范》解读[J]. 中国防痨杂志,2022,44(5):438-441. [16] 加依那提·金格斯,王新旗,刘年强,等. 387名结核分枝杆菌潜伏感染者预防性治疗服药完成情况及影响因素分析[J]. 中国防痨杂志,2024,46(12):1496-1503. [17] 中华人民共和国国家卫生健康委员会办公厅,中华人民共和国教育部办公厅. 关于印发中国学校结核病防控指南的通知(国卫办疾控函〔2020〕910号)[EB/OL]. (2020-10-16)[2024-01-01]. https://www.gov.cn/zhengce/zhengceku/2020-12/05/5567137/files/85d293d4f3e04bacb420f252c2189278.pdf. [18] 庞娜,李胜君,徐春琳. 绝经后女性维生素D营养状况与血脂及骨密度的关系[J]. 中国骨质疏松杂志,2024,30(10):1444-1448. [19] Wang CY, Hu YL, Wang YH, et al.Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011-2012[J]. Infect Drug Resist, 2019, 12: 2251-2257. [20] Ismail I, Adi S, Basri M, et al.Vitamin D receptor gene variations and tuberculosis susceptibility: Insights from Indonesian populations[J]. Tuberk Toraks, 2025, 73(1): 39-51. [21] Papagni R, Pellegrino C, Di Gennaro F, et al.Impact of vitamin D in prophylaxis and treatment in tuberculosis patients[J]. Int J Mol Sci, 2022, 23(7): 3860. [22] Bavi H, Hosseini SA, Ekrami A, et al.Effect of vitamin D supplementation on the treatment of pulmonary tuberculosis patients in different polymorphisms of the vitamin D receptor[J]. Adv Biomed Res, 2024, 13: 102. [23] Balasubramanian A, Kunchala K, Shahbaz A, et al.Association of vitamin D deficiency as an independent risk factor for myocardial infarction and its therapeutic implications: A systematic review[J]. Cureus, 2025, 17(1): e77375. [24] 罗士欢,赵斌,刘佳,等. 3 905例体检人群维生素D水平现状及影响因素研究[J]. 临床内科杂志,2019,36(10):681-684. |